Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SPRY
#2601
ARS Pharmaceuticals, Inc. Common Stock
8.140
0
USD
+1.75%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.75%
Monthly Change
-3.10%
6 month change
-11.62%
Year Change
-11.62%
Previous Close
8.000
0
Open
8.140
0
Bid
Ask
Low
8.140
0
High
8.140
0
Volume
64
Markets
US Stock Market
Healthcare
SPRY
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
35.14 M
94.4 M
96.5 M
98.12 M
99.3 M
—
Valuation ratios
Enterprise value
—
584.84 M
467.51 M
984.35 M
1.21 B
5.11 B
Price to earnings ratio
—
-9.68
-9.79
131.88
-6.7
-133.34
Price to sales ratio
—
255.65
17.71 K
12.12
13.63
49.67
Price to cash flow ratio
—
-8.39
-8.96
79.73
-6.72
-104.24
Price to book ratio
—
1.23
2.3
4.21
10.05
14.61
Enterprise value to EBITDA ratio
—
—
-6.93
-338.96
-5.99
-82.31
Profitability ratios
Return on assets %
-0.27
-0.12
-0.23
0.02
-0.52
-0.51
Return on equity %
-0.29
-0.13
-0.24
0.03
-1.5
-1.09
Return on invested capital %
-490.45
-367.52
-7 803.52
-118.26
-2 307.86
—
Gross margin %
100
100
100
100
97.44
400
Operating margin %
-84.51 K
-2 698.78
-225.07 K
-3.46
-212.92
-1 080.53
EBITDA margin %
-83.67 K
—
-224.82 K
-3.26
-221.09
-1 083.36
Net margin %
-84.41 K
-2 635.41
-181.22 K
8.97
-203.25
-1 015.77
Liquidity ratios
Quick ratio
—
—
—
14.04
6.48
29.14
Current ratio
17.56
51.01
96.92
14.26
7.28
31.11
Inventory turnover
—
—
—
0
0.12
—
Asset turnover
0
0
0
0.31
0.25
0.25
Solvency ratios
Debt to assets ratio
0.02
0
—
—
0.29
—
Debt to equity ratio
0.02
0
—
—
0.84
—
Long term debt to total assets ratio
0
0
—
—
0.29
—
Long term debt to total equity ratio
0
0
—
—
0.84
—
Per share metrics
Operating cash flow per share
—
-1
-0.62
0.13
-1.73
-1.74
EBIT per share
—
-0.89
-0.71
-0.03
-1.84
-1.82
EBITDA per share
—
—
-0.71
-0.03
-1.89
-1.83
Total debt per share
—
0.01
—
—
0.98
—
Cash per share
—
6.87
2.4
3.07
2.49
10.66
Net current asset value per share
—
6.95
2.43
3.26
2.89
12.28
Tangible book value per share
—
6.83
2.42
2.44
1.01
6.44
Working capital per share
—
6.81
2.41
3.04
2.49
10.62
Book value per share
—
6.83
2.42
2.51
1.16
6.94
News
ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)
Leerink raises ARS Pharmaceuticals stock price target on sales expansion
Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript
ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates
Canadian Natural to Report Q4 Earnings: What's in the Offing?
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Raymond James reiterates Strong Buy on ARS Pharmaceuticals stock
ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)
What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)
Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)